Immunis, Inc.
Clinical trials sponsored by Immunis, Inc., explained in plain language.
-
Can stem cell secretions help seniors regain muscle power?
Disease control OngoingThis study tests a treatment called IMM01-STEM, made from stem cell secretions, to see if it safely improves muscle strength and walking speed in seniors aged 60-80 who have both obesity and muscle loss (sarcopenic obesity). About 55 participants will receive either the treatment…
Phase: PHASE2 • Sponsor: Immunis, Inc. • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New hope for patients with sarcopenic obesity unable to join clinical trials
Disease control TEMPORARILY_NOT_AVAILABLEThis program provides expanded access to an experimental treatment (IMM01-STEM) for people with sarcopenic obesity—a condition where muscle loss and excess body fat occur together. It is designed for patients who cannot join other clinical trials due to location, eligibility, or …
Sponsor: Immunis, Inc. • Aim: Disease control
Last updated May 22, 2026 13:54 UTC